Perimeter Medical Imaging AI Announces Closing of Final Tranche of Prospectus Offering for $2.25 Million, Total Gross Proceeds of $5.35 Million Raised Under Prospectus Offering.

Perimeter Medical Imaging AI has closed the second tranche of its prospectus offering, raising $2.25 million for a total of $5.35 million. The company plans to use the net proceeds for technology commercialization, clinical evidence, and product development, as well as for working capital and general corporate purposes. Each unit consists of one common share and one warrant, exercisable at $0.35 for 60 months.

Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) has successfully closed the second tranche of its prospectus offering, raising $2.25 million. This brings the total gross proceeds from the offering to approximately $5.35 million [2]. The company has issued a total of 17,849,468 units, with each unit consisting of one common share and one warrant exercisable at $0.35 for a period of 60 months [2].

The funds raised will be used to support the commercialization of the company's technology, establish clinical evidence, and continue product development. Additionally, the net proceeds will be utilized for working capital and other general corporate purposes. Adrian Mendes, an officer of the company, purchased a total of 3,333,334 units under the offering [2].

Perimeter Medical Imaging AI is a medical technology company focused on transforming cancer surgery with ultra-high-resolution, real-time, advanced imaging tools. The company's Perimeter Optical Coherence Tomography (OCT) system provides cross-sectional, real-time margin visualization of tissue microstructures during surgical procedures [1].

References:
[1] https://stockhouse.com/companies/bullboard?symbol=v.pink
[2] https://finance.yahoo.com/news/perimeter-announces-closing-final-tranche-214000120.html